InvestorsHub Logo
Followers 4
Posts 60
Boards Moderated 0
Alias Born 08/20/2022

Re: bioaq_sh post# 129775

Tuesday, 08/23/2022 3:16:11 AM

Tuesday, August 23, 2022 3:16:11 AM

Post# of 149033
feb 2017 - Quoting Article Headline: 'Babette Pettersen, Chief Commercial Officer Steps Down from BioAmber Inc' - BioAmber Inc. announced that Ms. Babette Pettersen, Chief Commercial Officer, was stepping down from her position, effective immediately. Moving forward, there will no longer be a Chief Commercial Officer position at BioAmber, and Ms. Pettersen will not be replaced. Ms. Pettersen may assist BioAmber in an advisory role going forward.

I'm confused by the statement from the article: "Moving forward, there will no longer be a Chief Commercial Officer position at BioAmber, and Ms. Pettersen will not be replaced."

Confused because according to Mr. Hitoshi Araki (linkedin page) was Bioamber Sarnia's Board Director, Chief Commercial Officer from 04/2017 - 11/2017. - Hitoshi Araki Linkedin Page

It's understood with 40% equity in Bioamber Sarnia, Mitsui would have somebody on Bioamber's BOD, and pleased Bioamber was able to fill the Chief Commercial Officer position BUT after stating the above "moving forward....." in 02/2017. It's also interesting timing for the Chief Commericial Officer because of the 08/2017 security agreement between Bioamber & Mitsui.

Maybe Bioamber's press release meant Bioamber Inc save and except Bioamber Sarnia. Or maybe the linkedin page is an unrelieable source and should just rely on Bioamber's filings, reports, company statements & press releases.


Guessing i'll be labelled as a conspiracy theorist if i mention together - Ms. Babette Pettersen now VP Europe at Lanzatech and quote the following 04/2011 article LanzaTech and LCY to Target Bio-based Chemicals Market ;

"'LanzaTech and LCY to Target Bio-based Chemicals Market - Mr Bowei Lee, CEO and Chairman of LCY, says it is a proudly strategic intellection for LCY to pursue advanced technology. “The benefits may expand far beyond the impact on company revenue in this case,” Mr Lee says. “We value this opportunity as the essential step to a future with unlimited potential as we again fulfill our promise of effectuating green technology and being a resident of global village.”

Mr Lee says LCY plans to investigate alternative bio-C2 to C5 feedstock as raw materials, replacing petroleum oil for LCY’s current portfolio of products such as TPE, PP, solvents, and methanol derivatives. LCY is also looking to further developments in bio green products including bio-plastics and bio-fuels."
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.